Corix Bioscience (Corix Bioscience) Total Liabilities : $0.79 Mil (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Total Liabilities?

Corix Bioscience's Total Liabilities for the quarter that ended in Sep. 2017 was $0.79 Mil.

Corix Bioscience's quarterly Total Liabilities increased from Mar. 2017 ($0.00 Mil) to Jun. 2017 ($3.96 Mil) but then declined from Jun. 2017 ($3.96 Mil) to Sep. 2017 ($0.79 Mil).

Corix Bioscience's annual Total Liabilities declined from Jan. 2014 ($0.02 Mil) to Jan. 2015 ($0.00 Mil) but then increased from Jan. 2015 ($0.00 Mil) to Dec. 2016 ($5.76 Mil).

Corix Bioscience Total Liabilities Historical Data

The historical data trend for Corix Bioscience's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Total Liabilities Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Total Liabilities

Get a 7-Day Free Trial

0.01

0.02

5.76

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Total Liabilities	Get a 7-Day Free Trial															6.01	5.76	-	3.96	0.79

Corix Bioscience Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Corix Bioscience's Total Liabilities for the fiscal year that ended in Dec. 2016 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.687	+	(5.077	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.76

Total Liabilities	=	Total Assets (A: Dec. 2016 )	-	Total Equity (A: Dec. 2016 )
	=	11.37	-	5.606
	=	5.76

Corix Bioscience's Total Liabilities for the quarter that ended in Sep. 2017 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.786	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.79

Total Liabilities	=	Total Assets (Q: Sep. 2017 )	-	Total Equity (Q: Sep. 2017 )
	=	4.344	-	3.558
	=	0.79

Corix Bioscience Total Liabilities Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines